Experimental studies of potential analgesics for the treatment of chemotherapy-evoked painful peripheral neuropathies

Pain Medicine

Volumn 9, Issue 5, 2008, Pages 505-517

  Xiao, Wenhua ^a   Naso, Lina ^a   Bennett, Gary J ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Allodynia; Amitriptyline; Baclofen; Calcium channels; Chemotherapy; Hyperalgesia; Mexiletine; Neuropathic pain; Oxcarbazepine; Paclitaxel; Topiramate; Tramadol

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BACLOFEN; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; LEVACECARNINE; MEXILETINE; NMED 126; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXCARBAZEPINE; PACLITAXEL; SODIUM CHANNEL BLOCKING AGENT; TOPIRAMATE; TRAMADOL; VENLAFAXINE;

ALLODYNIA; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; HINDLIMB; HYPERALGESIA; MALE; MECHANICAL STIMULATION; NONHUMAN; PERIPHERAL NEUROPATHY; RAT;

AMITRIPTYLINE; ANALGESICS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BACLOFEN; BEHAVIOR, ANIMAL; CARBAMAZEPINE; FRUCTOSE; HUMANS; HYPERALGESIA; MALE; MEXILETINE; PACLITAXEL; PAIN; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; TRAMADOL;

EID: 48449090565     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2007.00301.x     Document Type: Article

References (77)

1. Polomano RP, Bennett GJ. Chemotherapy-evoked painful peripheral neuropathy. Pain Med 2001;2:8-14.
2. Verstappen CC, Heimans JJ, Hoekman K, Postma TJ. Neurotoxic complications of chemotherapy in patients with cancer: Clinical signs and optimal management. Drugs 2003;63:1549-63.
3. Dougherty PM, Cata JP, Cordella JV, Burton A, Weng HR. Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 2004;109:32-42.
4. Uhm JH, Yung WK. Neurologic complications of cancer therapy. Curr Treat Options Neurol 1999;1:428-37.
5. Bosnjak S, Jelic S, Susnjar S, Luki V. Gabapentin for relief of neuropathic pain related to anticancer treatment: A preliminary study. J Chemother 2002;14:214-9.
6. Caraceni A, Zecca E, Bonezzi C, et al. Gabapentin for neuropathic cancer pain: A randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol 2004;22:2909-17.
7. Wong GY, Michalak JC, Sloan JA, et al. A phase III double blinded, placebo controlled, randomized trial of gabapentin in patients with chemotherapy-induced peripheral neuropathy: A North Central Cancer Treatment Group study. J Clin Oncol 2005;23(Suppl):8001.
8. Renno SI, Rao RD, Sloan J, et al. The efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: A phase III randomized, double blind, placebo-controlled NCCTG trial, N01C2. J Clin Oncol 2006;24:8530.
9. Kontinen VK, Meert TF. Predictive validity of neuropathic pain models in pharmacological studies with behavioral outcome in rat: A systematic review. In: Dostrovsky JO, Carr DB, Koltzenburg M, eds. Proceedings of the 10th World Congress on Pain. Progress in Pain Research and Management. 2003;24:489-98.
10. Flatters SJL, Bennett GJ. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction. Pain 2006;122:245-57.
11. Siau C, Xiao WH, Bennett GJ. Paclitaxel- and vincristine-evoked painful peripheral neuropathies: Loss of epidermal innervation and activation of Langerhans cells. Exp Neurol 2006;201:507-14.
12. Polomano R, Clark U, Mannes AJ, Bennett GJ. A painful peripheral neuropathy in rat produced by the chemotherapeutic drug, paclitaxel. Pain 2001;94:293-304.
13. Flatters SJL, Bennett GJ. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain 2004;109:150-61.
14. Xiao WH, Bennett GJ. Synthetic omega-conopeptides applied to the site of nerve injury suppress neuropathic pains in rats. J Pharmacol Exp Ther 1995;274:666-72.
15. Chaplan SR, Pogrel JW, Yaksh TL. Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J Pharmacol Exp Ther 1994;269:1117-23.
16. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: An evidence based proposal. Pain 2005;118:289-305.
17. Snutch TP, Feng ZP, Berlardetti F, et al. Novel N-type calcium channel blockers efficacious in animal models of chronic pain. 226th American Chemical Society National Meeting, New York, 2003: Paper no. 6.
18. Shadiack AM, Molino LJ, Yagel SK. The novel anticonvulsant topiramate is antiallodynic in a rat model of neuropathic pain. Analgesia 1999;4:173-9.
19. Hao JX, Xu XJ, Urban L, Wiesenfeld-Hallin Z. Repeated administration of systemic gabapentin alleviates allodynia-like behaviors in spinally injured rats. Neurosci Lett 2000;280:211-4.
20. Xiao W, Boroujerdi A, Bennett GJ, Luo ZD. Chemotherapy-evoked painful peripheral neuropathy: Analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit. Neuroscience 2007;144:714-20.
21. Smith-Swintosky VL, Zhao B, Shank RP, Plata-Salaman CR. Topiramate promotes neurite outgrowth and recovery of function after nerve injury. Neuroreport 2001;12:1031-4.
22. Bischofs S, Zelenka M, Sommer C. Evaluation of topiramate as an anti-hyperalgesic and neuroprotective agent in the peripheral nervous system. J Peripher Nerv Syst 2004;9:70-8.
23. Benoliel R, Tal M, Eliav E. Effects of topiramate on the chronic constriction injury model in the rat. J Pain 2006;7:878-83.
24. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983;16:109-10.
25. Flatters SJL, Xiao WH, Bennett GJ. Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful neuropathy. Neurosci Lett 2006;397:219-23.
26. Siau C, Bennett GJ. Dysregulation of neuronal calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy. Anesth Analg 2006;102:1485-90.
27. Ardid D, Guilbaud G. Antinociceptive effects of acute and "chronic" injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats. Pain 1992;49:279-87.
28. Field MJ, McCleary S, Hughes J, Singh L. Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain 1999;80:391-8.
29. Esser MJ, Chase T, Allen GV, Sawynok J. Chronic administration of amitriptyline and caffeine in a rat model of neuropathic pain: Multiple interactions. Eur J Pharmacol 2001;430:211-8.
30. Hofmann HA, De Vry J, Siegling A, Spreyer P, Denzer D. Pharmacological sensitivity and gene expression analysis of the tibial nerve injury model of neuropathic pain. Eur J Pharmacol 2003;470:17-25.
31. Smith GD, Harrison SM, Birch PJ, et al. Increased sensitivity to the antinociceptive activity of (+/-)-baclofen in an animal model of chronic neuropathic, but not chronic inflammatory hyperalgesia. Neuropharmacol 1994;33:1103-8.
32. Idanpaan-Heikkila JJ, Guilbaud G. Pharmacological studies on a rat model of trigeminal neuropathic pain: Baclofen, but not carbamazepine, morphine or tricyclic antidepressants, attenuates the allodynia-like behaviour. Pain 1999;79:281-90.
33. Jett MF, McGuirk J, Waligora D, Hunter JC. The effects of mexiletine, desipramine and fluoxetine in rat models involving central sensitization. Pain 1997;69:161-9.
34. Nozaki-Taguchi N, Chaplan SR, Higuera ES, Ajakwe RC, Yaksh TL. Vincristine-induced allodynia in the rat. Pain 2001;93:69-76.
35. Erichsen HK, Hao JX, Xu XJ, Blackburn-Munro G. A comparison of the antinociceptive effects of voltage-activated Na+ channel blockers in two rat models of neuropathic pain. Eur J Pharmacol 2003;458:275-82.
36. Fox A, Gentry C, Patel S, Kesingland A, Bevan S. Comparative activity of the anti-convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin in a model of neuropathic pain in the rat and guinea-pig. Pain 2003;105:355-62.
37. Jang Y, Kim ES, Park SS, Lee J, Moon DE. The suppressive effects of oxcarbazepine on mechanical and cold allodynia in a rat model of neuropathic pain. Anesth Analg 2005;101:800-6.
38. Apaydin S, Uyar M, Karabay NU, et al. The antinociceptive effect of tramadol on a model of neuropathic pain in rats. Life Sci 2000;66:1627-37.
39. Tsai YC, Sung YH, Chang PJ, Kang FC, Chu KS. Tramadol relieves thermal hyperalgesia in rats with chronic constriction injury of the sciatic nerve. Fundam Clin Pharmacol 2000;14:335-40.
40. Courteix C, Bardin M, Chantelauze C, Lavarenne J, Eschalier A. Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics. Pain 1994;57:153-60.
41. Lindner MD, Bourin C, Chen P, et al. Adverse effects of gabapentin and lack of anti-allodynic efficacy of amitriptyline in the streptozotocin model of painful diabetic neuropathy. Exp Clin Psychopharmacol 2006;14:42-51.
42. Patel S, Naeem S, Kesingland A, et al. The effects of GABA(B) agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat. Pain 2001;90:217-26.
43. Lynch JJ, 3rd, Wade CL, Zhong CM, Mikusa JP, Honore P. Attenuation of mechanical allodynia by clinically utilized drugs in a rat chemotherapy-induced neuropathic pain model. Pain 2004;110:56-63.
44. Esser MJ, Sawynok J. Acute amitriptyline in a rat model of neuropathic pain: Differential symptom and route effects. Pain 1999;80:643-53.
45. Marchand F, Alloui A, Pelissier T, et al. Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat. Brain Res 2003;980:117-20.
46. Durand JP, Goldwasser F. Dramatic recovery of paclitaxel-disabling neurosensory toxicity following treatment with venlafaxine. Anticancer Drugs 2002;13:777-80.
47. Durand JP, Brezault C, Goldwasser F. Protection against oxaliplatin acute neurosensory toxicity by venlafaxine. Anticancer Drugs 2003;14:423-5.
48. Wilson RH, Lehky T, Thomas RR, et al. Acute oxaliplatin-induced peripheral nerve hyperexcitability. J Clin Oncol 2002;20:1767-74.
49. Durand JP, Alexandre J, Guillevin L, Goldwasser F. Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy. Anticancer Drugs 2005;16:587-91.
50. Amir R, Argoff CE, Bennett GJ, et al. The role of sodium channels in chronic inflammatory and neuropathic pain. J Pain 2006;7(Suppl3):S1-S29.
51. Esser MJ, Sawynok J. Caffeine blockade of the thermal antihyperalgesic effect of acute amitriptyline in a rat model of neuropathic pain. Eur J Pharmacol 2000;399:131-9.
52. Malan TP, Mata HP, Porreca F. Spinal GABA(A) and GABA(B) receptor pharmacology in a rat model of neuropathic pain. Anesthesiology 2002;96:1161-7.
53. Jasmin L, Rabkin SD, Granato A, Boudah A, Ohara PT. Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex. Nature 2003;424:316-20.
54. Devor M, Seltzer Z. Pathophysiology of damaged nerve and neuropathic pain. In: Wall PD, Melzack R, eds. Textbook of Pain, 4th edition. New York: Churchill Livingstone; 1999:129-64.
55. Xiao WH, Bennett GJ. Spontaneous discharge in primary afferent fibers in paclitaxel-evoked neuropathic pain in the rat. In: Abstracts: 11th World Congress on Pain. Seattle, WA: IASP Press; 2005: 426.
56. Chapman V, Ng J, Dickenson AH. A novel spinal action of mexiletine in spinal somatosensory transmission of nerve injured rats. Pain 1998;77:289-96.
57. Joshi SK, Mikusa JP, Hernandez G, et al. Involvement of the TTX-resistant sodium channel Nav 1.8 in inflammatory and neuropathic, but not post-operative, pain states. Pain 2006;123:75-82.
58. Staats PS, Yearwood T, Charapata SG, et al. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: A randomized controlled trial. JAMA 2004;291:63-70.
59. Matthews EA, Dickenson AH. Effects of ethosuximide, a T-type C2+) channel blocker, on dorsal horn neuronal responses in rats. Eur J Pharmacol 2001;415:141-9.
60. Dogrul A, Gardell LR, Ossipov MH, et al. Reversal of experimental neuropathic pain by T-type calcium channel blockers. Pain 2003;105:159-68.
61. Löscher W, Schmidt D. New horizons in the development of antiepileptic drugs: Innovative strategies. Epilepsy Res 2006;69:183-272.
62. Bian F, Li Z, Offord JD, et al. Calcium channel alpha 2 -delta type I subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdale, and spinal cord: An ex vivo autoradiographic study in alpha 2 -delta type 1 genetically modified mice. Brain Res 2006;1075:68-80.
63. Matsumoto M, Inoue M, Hald A, Xie W, Ueda H. Inhibition of paclitaxel-induced A-fiber-hypersensitization by gabapentin. J Pharmacol Exp Ther 2006;318:735-40.
64. Ambrosio AF, Soares-da-Silva P, Carvalho CM, Carvalho AP. Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024. Neurochem Res 2002;27:121-30.
65. Kiguchi S, Imamura T, Ichikawa K, Kojima M. Oxcarbazepine antinociception in animals with inflammatory pain or diabetic neuropathy. Clin Exp Pharmacol Physiol 2004;31:57-64.
66. Lersch C, Schmelz R, Eckel F, et al. Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer. Clin Colorectal Cancer 2002;2:54-8.
67. Leppert W, Luczak J. The role of tramadol in cancer pain treatment - A review. Support Care Cancer 2005;13:5-17.
68. Okuducu H, Onal SA. Is nitric oxide involved in the antinociceptive activity of tramadol? Findings in a rat model of neuropathic pain. Agri 2005;17:31-40.
69. Wieczorkiewicz-Plaza A, Plaza P, Maciejewski R, Czuczwar M, Przesmycki K. Effect of topiramate on mechanical allodynia in neuropathic pain model in rats. Pol J Pharmacol 2004;56:275-8.
70. Kudin AP, Debska-Vielhaber G, Vielhaber S, Elger CE, Kunz WS. The mechanism of neuroprotection by topiramate in an animal model of epilepsy. Epilepsia 2004;45:1478-87.
71. Carroll DG, Kline KM, Malnar KF. Role of topiramate for the treatment of painful diabetic peripheral neuropathy. Pharmacothery 2004;24:1186-93.
72. Thienel U, Neto W, Schwabe SK, Vijapurkar U. Topiramate in painful diabetic polyneuropathy: Findings from three double-blind placebo-controlled trials. Acta Neurol Scand 2004;110:221-31.
73. Cata JP, Weng HR, Dougherty PM. Cyclooxygenase inhibitors and thalidomide ameliorate vincristine-induced hyperalgesia in rats. Cancer Chemother Pharmacol 2004;54:391-7.
74. Ghirardi O, Lo Giudice P, Pisano C, et al. Acetyl-L-carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties. Anticancer Res 2005;25:2681-7.
75. Ghirardi O, Vertechy M, Vesci L, et al. Chemotherapy-induced allodinia: Neuroprotective effect of acetyl-L-carnitine. In Vivo 2005;19:631-7.
76. Zhu CZ, Wilson SG, Mikusa JP, et al. Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities. Eur J Pharmacol 2004;506:107-18.
77. Lynch JJ, 3rd, Wade CL, Mikusa JP, Decker MW, Honore P. ABT-594 (a nicotinic acetylcholine agonist): Anti-allodynia in a rat chemotherapy-induced pain model. Eur J Pharmacol 2005;509:43-8.